Endocrine Society Publishes First Gender Dysphoria Clinical Guideline
The Endocrine Society published its first clinical practice guideline on the endocrine treatment of transsexual persons, recommending suppression of puberty with GnRH analogues from Tanner stage 2 until age 16. Co-authored by Dutch Protocol pioneer Peggy Cohen-Kettenis, the guideline incorporated the Dutch approach into mainstream endocrinology, establishing international medical standards for treating gender dysphoria in adolescents.
Impact & Significance
Legitimised puberty blocker treatment within mainstream medical practice globally, providing the clinical framework that NHS England and other national health services would adopt for their gender identity services.
Reference Record
- Date
- September 2009
- Era
- 2000-2009
- Sources
- 2
This timeline entry is being migrated into the reference platform. Source metadata and editorial review status will be strengthened as each topic is upgraded.